Abstract
The ability of the carcinogen chromium(VI) to affect the basal and zinc-inducible expression of liver metallothionein was examined in 14- and 18-day chicken embryos in vivo. Metallothionein expression varied with the stage of embryo development, with basal steady-state mRNA levels being approximately three times lower in livers of 18-day versus 14-day chicken embryos. Chromium(VI) treatment had no effect on the basal steady-state levels of metallothionein mRNA and protein in either 14- or 18-day chicken embryo liver. Treatment of 14-day embryos with zinc(II) resulted in a 3- to 5-fold increase in steady-state levels of metallothionein mRNA in liver. Pre-treatment of 14-day embryos with chromium(VI) inhibited the zinc(II)-induced increase in steady-state levels of metallothionein mRNA and protein in liver by 30-50%. In contrast, chromium(VI) and/or zinc(II) treatments had no effect on steady-state levels of beta-actin mRNA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
